Table 1

Overview of studies presenting preference based HRQL weights for HIV/AIDS in sub-Saharan Africa.

Author

Setting

AIDS population

Sub-analyses

VAS¹⁾

TTO

SG

EQ-5D index

Hughes

South Africa

WHO stages 3 or 4

General community

0.80

(2004)

(Cape Town)

or CD4<200

Awaiting ART

0.60

Jelsma

South Africa

WHO stages 3 or 4

General community

0.80

(2005)

(Cape Town)

or CD4<200

Awaiting ART

0.62

ART (1 month)

0.70

ART (3 months)

0.71

ART (6 months)

0.74

ART (12 months)

0.76

Louwagie

South Africa

WHO stage 4 or

ART (own health)

0.66

0.80

(2007)

(Free State)

CD4<200

Awaiting ART

0.62

0.69

Lara

Uganda

WHO stages

Own health (ART and non ART)

0.50 and 0.55

(2008)

(Entebbe)

2, 3 or 4

WHO stage 2 (ART and non ART)

0.59 and 0.63

0.75 and 0.78

0.50 and 0.51

WHO stage 3 (ART and non ART)

0.39 and 0.39

0.49 and 0.52

0.34 and 0.39

WHO stage 4 (ART and non ART)

0.17 and 0.15

0.20 and 0.27

0.19 and 0.19

Own health reassessed (ART and non ART)

0.78 and 0.66

1) VAS scores transformed from 0-100 scale to 0-1 scale to improve comparability.

Robberstad and Olsen Cost Effectiveness and Resource Allocation 2010 8:5   doi:10.1186/1478-7547-8-5